These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3683686)

  • 1. Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
    Krishna GG; Chusid P; Hoeldtke RD
    Nephron; 1987; 47(3):184-9. PubMed ID: 3683686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atrial natriuretic peptide on potassium-stimulated aldosterone secretion: potential relevance to hypoaldosteronism in man.
    Clark BA; Brown RS; Epstein FH
    J Clin Endocrinol Metab; 1992 Aug; 75(2):399-403. PubMed ID: 1386372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia.
    Adam WR
    Nephrology (Carlton); 2008 Dec; 13(6):459-64. PubMed ID: 18518934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR; Eggena P; Phillips D
    Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
    Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S
    J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
    Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperpotassemia and bradycardia in a bedridden elderly woman with selective hypoaldosteronism associated with low renin activity.
    Inada M; Iwasaki K; Imai C; Hashimoto S
    Intern Med; 2010; 49(4):307-13. PubMed ID: 20154436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.
    Tan SY; Burton M
    Arch Intern Med; 1981 Jan; 141(1):30-3. PubMed ID: 7004370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient hyporeninemic hypoaldosteronism in acute glomerulonephritis.
    Watanabe T; Nitta K
    Pediatr Nephrol; 2002 Nov; 17(11):959-63. PubMed ID: 12432442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of hyperkalemia in systemic lupus erythematosus.
    Lee FO; Quismorio FP; Troum OM; Anderson PW; Do YS; Hsueh WA
    Arch Intern Med; 1988 Feb; 148(2):397-401. PubMed ID: 3277563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
    Sowers JR; Berg G; Martin VS; Mayes DM
    Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
    Stern N; Sowers JR; Tuck M; Eshkol A; Lunenfeld B; Rosenthal T
    J Hypertens; 1984 Apr; 2(2):209-14. PubMed ID: 6398336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered dopaminergic modulation of aldosterone secretion in cirrhosis.
    Bernardi M; De Palma R; Trevisani F; Malatesta R; Baraldini M; Cursaro C; Gasbarrini G
    Clin Sci (Lond); 1988 Feb; 74(2):137-43. PubMed ID: 3338258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
    Radó JP; Boer P
    Endokrinologie; 1979 Apr; 73(2):173-85. PubMed ID: 467373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.